Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA

Journal of B.U.ON.

Volumn 11, Issue 3, 2006, Pages 291-297

  Kornovski, Yavor ^a   Gorchev, G ^b  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

Cervical cancer; Neoadjuvant chemotherapy; Pelvic irradiation; Recurrence free survival; Stages IIB IVA

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; IFOSFAMIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; METASTASIS; MULTIMODALITY CANCER THERAPY; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PELVIS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 33751032264     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yalman D, Aras AB, Ozkok S et al. Prognostic factors in definitive radiotherapy of uterine cervical cancer. Eur J Gynaecol Oncol 2003; 24: 309-314.
2. Garipapaoglu M, Yalvak S, Kose MF et al. Treatment results and prognostic factors in inoperable carcinoma of the uterine cervix treated with external plus high dose brachytherapy. Cancer Lett 1999; 136: 17-26.
3. Scarabelli C, Zarrelli A, Gallo A, Visentin MC. Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIB-IVA cervical cancer. Cancer 1995; 76: 1019-1025.
4. Bolis G, van Zainten-Przybysz I, Scarfone G et al. Determinants of response to a cisplatin based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer. Gynecol Oncol 1996; 63: 62-65.
5. Namkoong SE, Park JS, Kim JW et al. Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol 1995; 59: 136-142.
6. Benedetti-Panici P, Greggi S, Colombo A et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2002; 20: 179-188. Comment in: J Clin Oncol 2002; 20: 2908-2909; discussion 2809-2810.
7. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AB, Mortel R. Analysis of factors contributing to treatment failures in stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 1980; 138: 550-556.
8. Sugawa T, Yamagata S, Yamamoto K. Chemotherapy for cancer of the cervix-current status and its evaluation. J Obstet Gynecol 1982; 8: 343-355.
9. Krebs H, Helmcamp BF, Sevin BU, Poliakoff SR, Nadji M, Averette HE. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Obstet Gynecol 1982; 59: 422-427.
10. O'Brien DM, Carmichael JA. Presurgical prognostic factors in carcinoma of the cervix, stage IB and IIA. Am J Obstet Gynecol 1988; 158: 250-254.
11. Sananes C, Giaroli A, Soderini A et al. Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomized controlled trial. Int J Gynecol Cancer 1998; 8: 441-450.
12. Aoki Y, Tomita M, Sato T et al. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol 2001; 83: 263-267.
13. Hwang YY, Moon H, Cho SH et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 2001; 82: 88-93.
14. Sardi J, Giaroli A, Sananes C et al. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma of cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer 1996; 6: 85-93.
15. Sananes C, Giaroli A, Soderini A et al. Neoadjuvant chemotherapy followed by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the cervix uteri: long-term follow-up of a pilot study. Eur J Gynaecol Oncol 1998; 19: 368-373.
16. Clamon G, Herndon J, Cooper R, Chang AY, Rosenman J, Green MR. Radiosensitization with carboplatin for patients with unresectable stage III nonsmall cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17: 4-11.
17. Zanetta G, Colombo A, Milani R, Placa F, Mangioni C. Long-term results of sequential postoperative treatment with vincristine, bleomycin, mitomycin-c, cisplatin and radiotherapy after surgery for high-risk patients with cervical carcinoma stage IB-IIA. Int J Gynecol Cancer 1995; 5: 40-44.
18. Sardi J, Sananes C, Giaroli A, Maya G, di Paula G. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990; 38: 486-493.
19. Benedetti-Panici P, Maneschi F, Cutillo G et al. Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical results. Cancer 1996; 78: 2359-2365.
20. Lopez-Graniel C, Reyes M, Chanona G et al. Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. Int J Gynecol Cancer 2001; 11: 210-219.